0001493152-23-023015.txt : 20230630
0001493152-23-023015.hdr.sgml : 20230630
20230630092505
ACCESSION NUMBER: 0001493152-23-023015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230628
FILED AS OF DATE: 20230630
DATE AS OF CHANGE: 20230630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trieu Vuong
CENTRAL INDEX KEY: 0001587074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21990
FILM NUMBER: 231059788
MAIL ADDRESS:
STREET 1: 4003 JIM BOWIE ROAD
CITY: AGOURA HILLS
STATE: CA
ZIP: 91301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncotelic Therapeutics, Inc.
CENTRAL INDEX KEY: 0000908259
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133679168
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29397 AGOURA RD.
STREET 2: #107
CITY: AGUORA HILLS
STATE: CA
ZIP: 91301
BUSINESS PHONE: 650-635-7000
MAIL ADDRESS:
STREET 1: 29397 AGOURA RD.
STREET 2: #107
CITY: AGUORA HILLS
STATE: CA
ZIP: 91301
FORMER COMPANY:
FORMER CONFORMED NAME: MATEON THERAPEUTICS INC
DATE OF NAME CHANGE: 20160613
FORMER COMPANY:
FORMER CONFORMED NAME: OXIGENE INC
DATE OF NAME CHANGE: 19930628
4
1
ownership.xml
X0407
4
2023-06-28
0
0000908259
Oncotelic Therapeutics, Inc.
OTLC
0001587074
Trieu Vuong
29397 AGOURA RD SUITE 107
AGOURA HILLS
CA
91301
1
1
1
0
CHAIRMAN AND CEO
0
Common Stock
2023-06-29
4
P
0
425000
0.021
A
92044217
D
Common Stock
2023-06-28
4
P
0
75000
0.026
A
91619217
D
Common Stock
16780384
I
By Autotelic, Inc.
Common Stock
6872529
I
By Spouse
On June 28, 2023, Dr. Trieu purchased 75,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.026. Further, on June 29, 2023, Dr. Trieu purchased 425,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.021.
/s/ Trieu, Vuong
2023-06-30